| 专论编号 | 物质名称 | 证书持有人 | 持有人ORG-ID和LOC-ID | 证书编号 | 发布日期 | 证书状态 | 到期续期 | 证书结束日期 | 证书类型 | 上一程序的结束日期 | 历史数据 程序类型|结论|日期 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1710 | Bisoprolol fumarate | MEHTA API PRIVATE LIMITED Boisar IN | 100020995;100042931 | CEP 2023-208 - Rev 00 | 2025/07/22 | Valid | 22/07/2030 | Chemical | 2025/07/22 | New application|CEP granted|22/07/2025 | |
| 2631 | Rosuvastatin calcium, Micronised | MANKIND PHARMA LIMITED New Delhi IN | 100040218;100065486 | CEP 2022-060 - Rev 02 | 2025/07/22 | Valid | 26/06/2028 | Chemical | 2025/07/23 | Administrative procedure|CEP granted|23/07/2025; Notification|CEP granted|10/06/2025; New application|CEP granted|26/06/2023 |
|
| 1376 | Triamcinolone | CORAL DRUGS PRIVATE LIMITED New Delhi IN | 100019182;100042823 | CEP 2022-370 - Rev 00 | 2025/07/22 | Valid | 22/07/2030 | Chemical | 2025/07/23 | New application|CEP granted|23/07/2025 | |
| 2768 | Fluticasone furoate, Process I | HOVIONE FARMACIENCIA S.A. Loures PT | 100001467;100000315 | CEP 2024-146 - Rev 00 | 2025/07/22 | Valid | 22/07/2030 | Chemical | 2025/07/23 | New application|CEP granted|23/07/2025 | |
| 383 | Chlorobutanol hemihydrate | OLPHA AS Olaine LV | 100002509;100000997 | CEP 2013-148 - Rev 02 | 2025/07/22 | Valid | Chemical | 2025/07/23 | Minor revision|CEP granted|23/07/2025; Notification|CEP granted|28/10/2024; Minor revision|Accepted - CEP remains valid|18/12/2020 |
||
| 1302 | Ciclopirox olamine | OLON S.P.A. Rodano IT | 100012085;100019537 | CEP 1999-085 - Rev 09 | 2025/07/22 | Valid | Chemical | 2025/07/23 | Minor revision|CEP granted|23/07/2025; Minor revision|Accepted - CEP remains valid|04/07/2024; Minor revision|Accepted - CEP remains valid|15/03/2023; Minor revision|Accepted - CEP remains valid|28/03/2022; Minor revision|CEP granted|13/09/2021; Minor revision|CEP granted|11/01/2021 |
||
| 67 | Folic acid hydrate | SRI KRISHNA PHARMACEUTICALS LIMITED Hyderabad IN | 100015104;100023787 | CEP 1997-076 - Rev 13 | 2025/07/22 | Valid | Chemical | 2025/07/23 | Minor revision|CEP granted|23/07/2025; Minor revision|CEP granted|05/03/2024; Monograph revision|Accepted - CEP remains valid|07/09/2022; Minor revision|CEP granted|20/05/2021 |
||
| 3132 | Mirabegron | VASUDHA PHARMA CHEM LIMITED Hyderabad IN | 100011811;100018603 | CEP 2024-198 - Rev 00 | 2025/07/22 | Valid | 22/07/2030 | Chemical | 2025/07/23 | New application|CEP granted|23/07/2025 | |
| 68 | Atropine sulfate | FLOWCHEM PHARMA PRIVATE LIMITED Sri Sathya Sai IN | 100054650;100096908 | CEP 2023-209 - Rev 00 | 2025/07/22 | Valid | 22/07/2030 | Chemical | 2025/07/23 | New application|CEP granted|23/07/2025 | |
| 1243 | Mitoxantrone hydrochloride | WUHAN CALMLAND PHARMACEUTICALS CO., LTD. Wuhan CN | 100049301;100083738 | CEP 2023-342 - Rev 00 | 2025/07/22 | Valid | 22/07/2030 | Chemical | 2025/07/23 | New application|CEP granted|23/07/2025 | |
| 1742 | Esketamine hydrochloride | AREVIPHARMA GMBH Radebeul DE | 100011616;100022155 | CEP 2022-404 - Rev 01 | 2025/07/22 | Valid | 21/06/2028 | Chemical | 2025/07/23 | Minor revision|CEP granted|23/07/2025; New application|CEP granted|21/06/2023 |
|
| 2334 | Letrozole, Form-III | HETERO LABS LIMITED Hyderabad IN | 100011681;100018664 | CEP 2012-145 - Rev 03 | 2025/07/22 | Valid | Chemical | 2025/07/23 | Minor revision|CEP granted|23/07/2025; Minor revision|CEP granted|22/02/2023; Monograph revision|Accepted - CEP remains valid|27/01/2021 |
||
| 685 | Povidone, K17 | BOAI NKY MEDICAL HOLDINGS LTD. Jiaozuo CN | 100051122;100089488 | CEP 2024-236 - Rev 00 | 2025/07/22 | Valid | 22/07/2030 | Chemical | 2025/07/23 | New application|CEP granted|23/07/2025 | |
| 2359 | Dorzolamide hydrochloride | CURIA SPAIN S.A.U. Boecillo ES | 100011649;100019586 | CEP 2010-115 - Rev 04 | 2025/07/22 | Valid | Chemical | 2025/07/23 | Minor revision|CEP granted|23/07/2025; Minor revision|CEP granted|15/11/2021; Notification|CEP granted|24/08/2021; Minor revision|CEP granted|04/12/2020 |
||
| 2736 | Imatinib mesilate | CDYMAX (INDIA) PHARMA PRIVATE LIMITED Bangalore IN | 100017076;100025868 | CEP 2018-262 - Rev 02 | 2025/07/22 | Valid | Chemical | 2025/07/23 | Renewal|CEP granted|23/07/2025; Minor revision|CEP granted|24/10/2022; Major revision|Rejected|18/08/2022 |
||
| 2541 | Quetiapine Fumarate | COHANCE LIFESCIENCES LIMITED Mumbai IN | 100011755;100090273 | CEP 2017-175 - Rev 02 | 2025/07/22 | Valid | Chemical | 2025/07/23 | Minor revision|CEP granted|23/07/2025; Notification|CEP granted|09/07/2024; Minor revision|Accepted - CEP remains valid|25/10/2023; Minor revision|Accepted - CEP remains valid|22/02/2024; Renewal|CEP granted|20/06/2023; Minor revision|CEP granted|13/09/2022; Notification|CEP granted|12/02/2021 |
||
| 260 | Amoxicillin trihydrate | SINOPHARM WEIQIDA PHARMACEUTICAL CO., LTD Datong CN | 100033465;100052362 | CEP 2019-244 - Rev 03 | 2025/07/22 | Valid | Chemical | 2025/07/23 | Renewal|CEP granted|23/07/2025; Minor revision|CEP granted|18/12/2023; Minor revision|CEP granted|29/09/2021 |
||
| . | Bovine Calf Serum, Defined, Supplemented, Cosmic | HYCLONE LABORATORIES LLC. Logan US | 100012797;100022115 | CEP 2000-080 - Rev 06 | 2025/07/22 | Valid | TSE | 2025/12/11 | Major revision|Accepted - CEP remains valid|11/12/2025; Major revision|Rejected|17/10/2025; Notification|CEP granted|23/07/2025; Notification|Accepted - CEP remains valid|10/05/2022; Notification|Rejected|25/03/2022; Notification|CEP granted|24/06/2020 |
||
| 2932 | Rivaroxaban | LEE PHARMA LIMITED Hyderabad IN | 100014849;100042625 | CEP 2022-339 - Rev 01 | 2025/07/21 | Valid | 06/11/2029 | Chemical | 2025/07/21 | Minor revision|CEP granted|21/07/2025; New application|CEP granted|06/11/2024 |
|
| 575 | Cholecalciferol concentrate (oily form), 1 000 000 IU/g, with all-rac-α-tocopherol, in Triglycerides, medium-chain | DSM-FIRMENICH SWITZERLAND AG Kaiseraugst CH | 100053293;100094111 | CEP 2021-055 - Rev 01 | 2025/07/21 | Valid | 16/11/2027 | Chemical and TSE | 2025/07/21 | Notification|CEP granted|21/07/2025; New application|CEP granted|16/11/2022 |
请输入需要查询的英文物质名称,证书持有人,证书编号,专论编号